Shearman & Sterling advised BofA Securities, Inc. and the other underwriters in Exact Sciences Corporation’s public offering of $1.15 billion aggregate principal amount of its 0.3750 percent Convertible Senior Notes due 2028 (including $150 million in aggregate principal amount of notes purchased by the underwriters pursuant to their fully exercised option to purchase additional notes) with an initial conversion price of approximately $121.84 per share of common stock.
BofA Securities, Inc. acted as sole book-running manager for the offering. Robert W. Baird & Co. Incorporated, Cowen and Company, LLC, William Blair & Company, L.L.C., BTIG, LLC and Stifel, Nicolaus & Company, Incorporated acted as co-managers in the offering.
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer.